The Mass Spectrometry metabolomics core has well established methodologies to provide qualitative and quantitative measures of specific metabolites such as amino acids, lipid-related metabolites including ceramides, phosphometabolites, and substrates of the citric acid cycle as well as drug metabolites. These measurements complement our methodologies to measure stable isotope abundance in a variety of molecules including fatty acids, amino acids, carbohydrates, and phosphometabolites. These methodologies in combination with our expertise in multi-compartment modeling offer the opportunity to not only to measure the concentrations of metabolites but also to understand how concentrations are determined by changes in the rate of appearance or disposal of a given analyte. It also allows us to determine the metabolic fates and dynamics of the metabolic network of various metabolic processes between various body compartments. The current facility has 11 different classes of mass spectrometer supported by 9 highly trained technical staff and supports over 50 investigators (40 of whom are NIH-funded). Currently <10% of the services undertaken are provided to investigators outside Mayo Clinic. The mass spectrometry Core is closely integrated to the NMRS core to complement our mutual strengths and is connected closely with the proteomics, genomics and microbiome programs which are all served by a common bioinformatics/bio statistics group. There are multiple requests for access to our facility from investigators from other national centers but only an expanded facility can respond to the increasing demands. In this application we propose the acquisition of three additional mass spectrometers and three additional technical staff so as to expand the analytical capabilities as well as the overall capacity of the core enabling an expansion of the services provided to a larger number of investigators both within and outside of the Mayo Clinic. The existing facilities currently provide assistance to investigators in isotope selection and experimental design as well as bioinformatics and mathematical modeling support thereby enabling the research objectives to be accomplished. The plan is to enable the program to be self-sustaining within a five year period. We have an established prioritization program for sample analysis that was approved by NIH review at the time of our CTSA grant renewal and that program will be extended to meet the requirement of the proposed comprehensive program. Thus the overall goal of this application is to expand the facility enabling us to offer the expertise and services to other national institutions thereby advancing metabolomics-based

Public Health Relevance

This proposal is prepared in response to RFA-RM-11-016: Regional Comprehensive Metabolomics Resource Cores (RCMRC) (U24) and will implement Mass Spectrometry based measures of labeled (by means of stable isotopes) or unlabeled metabolites. These methodologies in combination with our expertise in multi-compartment modeling offer the opportunity to measure the concentrations of metabolites but also their rates of appearance and disposal.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Hinton, David J; Vázquez, Marely Santiago; Geske, Jennifer R et al. (2017) Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects. Sci Rep 7:2496
Talbert, Erin E; Yang, Jennifer; Mace, Thomas A et al. (2017) Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities. Mol Cancer Ther 16:344-356
Zhang, Yuwen; Rao, Enyu; Zeng, Jun et al. (2017) Adipose Fatty Acid Binding Protein Promotes Saturated Fatty Acid-Induced Macrophage Cell Death through Enhancing Ceramide Production. J Immunol 198:798-807
Robinson, Matthew M; Dasari, Surendra; Konopka, Adam R et al. (2017) Enhanced Protein Translation Underlies Improved Metabolic and Physical Adaptations to Different Exercise Training Modes in Young and Old Humans. Cell Metab 25:581-592
Kazak, Lawrence; Chouchani, Edward T; Lu, Gina Z et al. (2017) Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity. Cell Metab 26:660-671.e3
Chang, Alice Y; Lalia, Antigoni Z; Jenkins, Gregory D et al. (2017) Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome. Metabolism 71:52-63
Lalia, Antigoni Z; Dasari, Surendra; Robinson, Matthew M et al. (2017) Influence of omega-3 fatty acids on skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults. Aging (Albany NY) 9:1096-1129
Hames, Kazanna C; Morgan-Bathke, Maria; Harteneck, Debra A et al. (2017) Very-long-chain ?-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial. Am J Clin Nutr 105:1552-1558
Hinshaw, Ling; Schiavon, Michele; Dadlani, Vikash et al. (2016) Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes. J Clin Endocrinol Metab 101:1954-62
Vella, Adrian; Jensen, Michael D; Nair, K Sreekumaran (2016) Eulogy for the Metabolic Clinical Investigator? Diabetes 65:2821-3

Showing the most recent 10 out of 77 publications